Natalie D’Amore is the Head of External Innovation at Seres Therapeutics, focused on building partnerships to advance Seres strategic goals. She has 20 years of experience in the industry joining Seres from Takeda Pharmaceuticals where she was Head of Oncology Partnerships. In this role she was responsible for building the Immuno-Oncology Portfolio through strategic collaborations with a network of biopharma companies and academic institutes as well as venture investments in early stage seed companies.. Natalie led an Incubator to drive innovative new concepts and was Director of a Research team to lead programs from conception to IND. At Millennium Pharmaceuticals she was a research scientist who led cell biology teams and was a project leader for programs that progressed into development. Prior to her industry experience she did her postdoctoral fellowship at the Sanford Burnham Institute in La Jolla CA in the lab of John Reed.